On July 23, 2019 Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, reported that it will release its financial results for the second quarter ended June 30, 2019 after the market closes on Tuesday, August 6, 2019 (Press release, Cellular Biomedicine Group, JUL 23, 2019, View Source [SID1234537667]).

The Company will host a conference call and webcast with the investment community on Tuesday, August 6th at 4:30 p.m. Eastern Time / Wednesday, August 7th at 4:30 a.m. China Standard Time featuring remarks by Tony Liu, Executive Director, CEO and CFO of CBMG.

What:
Cellular Biomedicine Group Second Quarter 2019 Results Conference Call

Date:
Tuesday, August 6, 2019

Time:
4:30 p.m. Eastern Time

Live Call:
Toll-Free: 1-855-327-6838
International: 1-604-235-2082

Webcast:
View Source

Replay:

Toll-Free: 1-844-512-2921
International: 1-412-317-6671
Conference ID: 10007371
(Available approximately two hours after the completion of the live call until 11:59 p.m. ET on August 20, 2019)

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!